Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Odor-Free Evaporation on Your Lab Bench

By Drug Discovery Trends Editor | July 2, 2014

EZ-2 Evaporator (Source: Genevac)Genevac announced a proprietary “odor reduction” function for its EZ-2 evaporator which enables it to be sited on the open bench rather than taking up valuable fume hood space.
 
Many solvent evaporators are routinely sited inside fume extraction hoods because residual solvent vapor, remaining in the chamber at the end of a run, can expose the operator to potentially harmful odors when the system is opened.
 
The EZ-2’s Reduce Odor function automatically adds a repeated vent and vacuum cycle to the end of a method, which purges the evaporation chamber of residual solvent vapors. Three settings are available to optimise vapor removal without releasing trapped solvent from the cold trap.
 
The EZ-2 evaporator draws on the expertise of Genevac’s engineers and the experiences of many scientists in the laboratory. Using advanced evaporation science, it has been designed specifically for productive, sample-safe solvent removal, be that concentration of samples, or complete drying. Genevac’s long experience in vacuum engineering has resulted in the creation of a compact sample concentrator combining great performance, ease of use and compatibility with all commonly used solvents and acids.
 
Compatible with a wide range of sample holders the EZ-2 easily integrates within the workflow of any laboratory. Smart evaporator software with auto-stop provides true walk-away automation – so simple and sample safe that anyone can use it with confidence. Featuring up to 10 on board solvent specific evaporation programs the EZ-2 automatically controls vacuum and temperature to enable rapid evaporation of a wide range of solvents whilst preventing bumping and cross contamination.
 
As well as the reduce odor option – users may also optimize their method for specific applications such as solvent keep, and to prevent over drying when handling volatile analytes. Options are also available to enable routine, safe removal of potentially explosive solvents such as diethyl ether or pentane and removal of acids including concentrated hydrochloric acid (HCl).
 
Date: June 18, 2014
Source: Genevac

Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE